Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/15890
Title: Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration.
Authors: Garcea, G
Jones, DJ
Singh, R
Dennison, AR
Farmer, PB
Sharma, RA
Steward, WP
Gescher, AJ
Berry, DP
First Published: 8-Mar-2004
Citation: BR J CANCER, 2004, 90 (5), pp. 1011-1015
Abstract: Studies in vitro and in animal models of colorectal and hepatocellular cancers suggest that curcumin is an effective chemopreventive agent. In this pilot trial, we investigated whether oral administration of curcumin results in concentrations of the agent in normal and malignant human liver tissue, which are sufficient to elicit pharmacological activity. In total, 12 patients with hepatic metastases from colorectal cancer received 450-3600 mg of curcumin daily, for 1 week prior to surgery. Levels of curcumin and its metabolites were measured by HPLC in portal and peripheral blood, bile and liver tissue. Curcumin was poorly available, following oral administration, with low nanomolar levels of the parent compound and its glucuronide and sulphate conjugates found in the peripheral or portal circulation. While curcumin was not found in liver tissue, trace levels of products of its metabolic reduction were detected. In patients who had received curcumin, levels of malondialdehyde-DNA (M(1)G) adduct, which reflect oxidative DNA changes, were not decreased in post-treatment normal and malignant liver tissue when compared to pretreatment samples. The results suggest that doses of curcumin required to furnish hepatic levels sufficient to exert pharmacological activity are probably not feasible in humans.
DOI Link: 10.1038/sj.bjc.6601623
ISSN: 0007-0920
Links: http://hdl.handle.net/2381/15890
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.